FOLD — AMICUS THERAPEUTICS INC

Ownership history in Bellevue Group AG  ·  3 quarters on record

This page tracks every 13F SEC filing in which Bellevue Group AG reported a position in AMICUS THERAPEUTICS INC (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.9% (2025 Q4)
Avg. % of fund
1.01%
First filed
2019 Q1
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 10,735,195 +10,585,195 +7056.8% 2.90% $152.9M $14.24
2019 Q2 UNCHANGED 150,000 — 0% 0.03% $1.9M $12.48
2019 Q1 INITIATED 150,000 — — 0.11% $2.0M —
% of Fund (quarterly)    FOLD price (monthly, adj. close)

Other funds also holding FOLD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 10.32% Sand Grove Capital Management LLP 3Y 7Y 7.95% PSquared Asset Management AG 3Y 7Y 6.99% CM Management, LLC 3Y 4.44% Prosight Management, LP 3Y 7Y 3.38% KRYGER CAPITAL Ltd 3Y 3.29% Athos Capital Ltd 3Y 7Y 3.27% Chicago Capital Management, LLC 3Y 7Y 2.92% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 2.75% Soleus Capital Management, L.P. 3Y 2.74%
← Back to Bellevue Group AG Holdings